Skip to main content
News Bald 11.2021
© Volker Lannert / Uni Bonn

News categories: Honors & Funding

Prof. Tobias Bald awarded with the Lisec-Artz Prize

Tobias Bald and Sebastian Kobold receive research award for their work on Tumor Immunobiology at the Cluster Science Days 2021

Professor Bald heads the research group „Tumor Immunobiology” as part of the Cluster of Excellence ImmunoSensation2, and is a member of the Transdisciplinary Research Area (TRA) "Life and Health“, both at the University of Bonn. He is now awarded with the Lisec-Artz price for his contributions to better understand the interactions between cancer cells and immune cells. His research focus is set on the role of the T-cell activating receptor CD226 during this interaction, with the goal to significantly improve cancer immunotherapy.

In addition to infections, the immune system also protects against cancer by recognizing and destroying malignant cells at an early stage. Tobias Bald and his team have been trying for years to better understand the interactions between cancer cells and immune cells. Recently, for example, he showed that cancer cells can weaken the immune system in previously unknown ways. Immune cells constantly need positive feedback in their fight against cancer cell. To evade an immune response, cancer cells deprive the immune cells of this positive signals. This weakens the immune cells so that the cancer cells can no longer be destroyed. The knowledge gained here is now to be implemented in cancer immunotherapy. “The tumor-induced loss of T-Cell receptors leads to an overall loss of T-Cell functionality. This phenomenon is what we now try to therapeutically tackle, in order to improve therapy for cancer patients.” Prof. Bald states.

The Lisec-Artz Price of 2021 was also awarded to Prof. Sebastian Kobold from the University Clinics of the Ludwig-Maximilians University Munich. Prof. Sebastian Kobold's research is also focused on the development of new treatments for cancer. Prof. Kobold and his team are targeting the body's immune system with synthetic proteins, enabeling immune cells to recognize and destroy cancer cells. At the same time, the method enables the cells of the defense system to migrate into malignant tissue unharmed and in a targeted manner. Prof. Kobold was able to carry out pioneering work in this area, because there is a need for immunotherapies beyond those already available for the treatment of advanced blood cancers like breast, lung or colon cancer.


Participating institutions and funding

The Lizec-Artz Prize is donated by the Bonn University Foundation and the Medical Faculty of the University of Bonn and endowed with 10,000 euros. The prize honors outstanding young scientists in cancer research in Germany.

The Cluster of Excellence ImmunoSensation2 at the University of Bonn is funded by the German Research Foundation (DFG).


Contact

Prof. Dr. Tobias Bald

Institute of Experimental Oncology

Medical Faculty, University of Bonn

University Hospital of Bonn

Venusberg-Campus 1

53127 Bonn

Tobias.Bald@ukbonn.de

Related news

Dermatologist Prof. Jörg Wenzel – from Bonn University Hospital (UKB) and the University of Bonn – leads the Bonn subproject within the new DFG-funded research consortium FOR 6059, which investigates the mechanisms underlying cutaneous lupus. © Bonn University Hospital (UKB) / Alessandro Winkler

News categories: Honors & Funding

New Research Group Investigates Cutaneous Lupus

—The German Research Foundation (DFG) is funding a new research group dedicated to investigating cutaneous lupus erythematosus, an autoimmune disease affecting the skin. A team from Bonn University Hospital (UKB) and the University of Bonn is participating in the collaborative research project “Investigating the Immunopathogenesis of Cutaneous Lupus Erythematosus” (FOR 6059), which is led by the Department of Dermatology at the University Hospital Tübingen.
View entry
With funding from the Corona Foundation, Dr Christina Mayer (right) is establishing her own junior research group and developing the field of neurovisual diagnostics at the Department of Neurology at UKB, headed by Prof Anne-Katrin Pröbstel (left).

News categories: Honors & Funding

The Retina as a Window into the Early Detection of Brain Diseases

—The retina is the only part of the central nervous system that can be examined non-invasively and at high resolution in living humans. Dr Christina Mayer and her team at Bonn University Hospital (UKB) and the University of Bonn aim to use this unique feature to detect inflammatory and vascular diseases of the brain earlier and more accurately, and to better understand how they develop. The Corona Foundation is providing €1 million to establish her junior research group. The programme gives outstanding early-career researchers the opportunity to qualify for a university professorship.
View entry
Prof. Joanna Kalucka joins Bonn as a Mercator Fellow and investigates how metabolic and inflammatory processes affect the inner lining of blood vessels.

News categories: Honors & Funding

Joanna Kalucka Joins Bonn as a Mercator Fellow

—Joanna Kalucka, Associate Professor at Aarhus University’s Department of Biomedicine, will join the Collaborative Research Centre (CRC) 1454 “Metaflammation and Cellular Programming” at the University of Bonn and Bonn University Hospital (UKB) as a Mercator Fellow Global from 2027. The German Research Foundation (DFG) is funding her fellowship through the “1000 Heads Plus” programme of the Federal Ministry of Research, Technology and Space (BMFTR).
View entry

Back to the news overview